The short version
9 companies supply this market — a reasonable cushion if one runs into trouble.
The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.
Abiraterone
Abiraterone acetate · ABIRATERONE ACETATE 250 mg/1 · Tablet, Film Coated · Oral · Novadoz Pharmaceuticals LLC
NDC 72205-0284-05 · 500 TABLET, FILM COATED in 1 BOTTLE · ANDA · View full market →
Medicare Part D
No Medicare Part D plan in CMS's quarterly files lists this product. That usually means it is discontinued, a repackager's listing, or a product no plan has added to its formulary.
How Part D pricing works →NADAC price per unit
No NADAC pricing on file for this NDC — NADAC covers drugs dispensed by retail community pharmacies.
Supply fragility
Not scored — fragility is computed for NADAC-priced NDCs.
90-day shortage risk (model v2)
0.1%chance of a new FDA shortage posting for abiraterone acetate (oral solid) in the next 90 days
sole-source market
For scale: the typical drug’s chance is about 0.1% — this one is in ordinary territory.
Backtested statistical model over the whole market, not this package alone. Model details →
Where it's made
- analysis · manufacture
- Msn Pharmaceuticals IncUnited Statesanalysis · manufacture
Establishments this product's FDA label declares, located via FDA registration data. How we built this →
Is this a "specialty" drug?
There's no legal definition — it meets 1 of 6 public criteria. Why that matters →
- Part D specialty tier
- Costs ≥ $950/fill · avg $1,826.30 per prescription
- Biologic (BLA)
- Injectable / infused
- Orphan-drug exclusivity
- REMS program
Regulatory
- Application
- ANDA210686
- TE code
- AB
- Approval date
- Jul 10, 2019
- Patents / exclusivity
- None on file
Shortage history
No FDA shortage reports for this drug or its presentations.
Recalls (this NDC)
No enforcement reports list this package NDC.
Manufacturers of Abiraterone acetate (Tablet, Film Coated)
| Labeler | Strength | First seen | Last seen |
|---|---|---|---|
| Apotex Corp. | ABIRATERONE ACETATE 500 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Bryant Ranch Prepack | ABIRATERONE ACETATE 500 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Florida Pharmaceutical Products, LLC | ABIRATERONE ACETATE 500 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Golden State Medical Supply, Inc. | ABIRATERONE ACETATE 500 mg/1 | Aug 12, 2026 | Sep 2, 2026 |
| Janssen Biotech, Inc. | ABIRATERONE ACETATE 500 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Mylan Pharmaceuticals Inc. | ABIRATERONE ACETATE 500 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Novadoz Pharmaceuticals LLC | ABIRATERONE ACETATE 500 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Novadoz Pharmaceuticals LLC | ABIRATERONE ACETATE 250 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Novugen Pharma (USA) LLC | ABIRATERONE ACETATE 500 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Novugen Pharma (USA) LLC | ABIRATERONE ACETATE 250 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Quallent Pharmaceuticals Health LLC | ABIRATERONE ACETATE 500 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
Roster from daily NDC Directory diffs — first/last seen dates start July 2026.
Cite this page
DrugDashboards, "Abiraterone — NDC 72205-0284-05," retrieved September 3, 2026, https://drugdashboards.com/drug/72205028405.
Free to cite with attribution — see how the data is put together.